124 related articles for article (PubMed ID: 1328923)
41. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
42. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus.
Mussap CJ; Burcher E
J Pharmacol Exp Ther; 1993 Aug; 266(2):1043-53. PubMed ID: 8394903
[TBL] [Abstract][Full Text] [Related]
43. Cyclic hexapeptide NK-2 antagonists.
Hölzemann G; Löw A; Harting J; Greiner HE
Int J Pept Protein Res; 1994 Aug; 44(2):105-11. PubMed ID: 7527014
[TBL] [Abstract][Full Text] [Related]
44. Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors.
Petitet F; Beaujouan JC; Saffroy M; Torrens Y; Chassaing G; Lavielle S; Besseyre J; Garret C; Carruette A; Glowinski J
J Neurochem; 1991 Mar; 56(3):879-89. PubMed ID: 1704425
[TBL] [Abstract][Full Text] [Related]
45. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
Maggi CA; Giuliani S; Ballati L; Lecci A; Manzini S; Patacchini R; Renzetti AR; Rovero P; Quartara L; Giachetti A
J Pharmacol Exp Ther; 1991 Jun; 257(3):1172-8. PubMed ID: 1710662
[TBL] [Abstract][Full Text] [Related]
46. Receptors mediating tachykinin-induced contractile responses in guinea-pig trachea.
Ireland SJ; Bailey F; Cook A; Hagan RM; Jordan CC; Stephens-Smith ML
Br J Pharmacol; 1991 Jun; 103(2):1463-9. PubMed ID: 1653074
[TBL] [Abstract][Full Text] [Related]
47. Agonist and antagonist binding to tachykinin peptide NK-2 receptors.
Buck SH; Shatzer SA
Life Sci; 1988; 42(26):2701-8. PubMed ID: 2838713
[TBL] [Abstract][Full Text] [Related]
48. Antagonists that demonstrate species differences in neurokinin-1 receptors.
Appell KC; Fragale BJ; Loscig J; Singh S; Tomczuk BE
Mol Pharmacol; 1992 Apr; 41(4):772-8. PubMed ID: 1373802
[TBL] [Abstract][Full Text] [Related]
49. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
[TBL] [Abstract][Full Text] [Related]
50. Interaction of amyloid beta protein (25-35) with tachykinin receptors.
Rovero P; Patacchini R; Renzetti AR; Brown M; Mizrahi J; Maggi CA; Giachetti A
Neuropeptides; 1992 Jun; 22(2):99-101. PubMed ID: 1328924
[TBL] [Abstract][Full Text] [Related]
51. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
52. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
53. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues.
Mantyh PW; Gates T; Mantyh CR; Maggio JE
J Neurosci; 1989 Jan; 9(1):258-79. PubMed ID: 2536418
[TBL] [Abstract][Full Text] [Related]
54. 3H-neurokinin A labels a specific tachykinin-binding site in the rat duodenal smooth muscle.
Bergström L; Beaujouan JC; Torrens Y; Saffroy M; Glowinski J; Lavielle S; Chassaing G; Marquet A; D'Orleans-Juste P; Dion S
Mol Pharmacol; 1987 Dec; 32(6):764-71. PubMed ID: 2826990
[TBL] [Abstract][Full Text] [Related]
55. Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.
Beresford IJ; Birch PJ; Hagan RM; Ireland SJ
Br J Pharmacol; 1991 Oct; 104(2):292-3. PubMed ID: 1665729
[TBL] [Abstract][Full Text] [Related]
56. Pharmacology of neurokinin receptors.
Regoli D; Nantel F
Biopolymers; 1991 May; 31(6):777-83. PubMed ID: 1718474
[TBL] [Abstract][Full Text] [Related]
57. Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut.
Wang Y; Badgery-Parker T; Lovas S; Chartrel N; Vaudry H; Burcher E; Conlon JM
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):827-32. PubMed ID: 1332683
[TBL] [Abstract][Full Text] [Related]
58. Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells.
Bellucci F; Meini S; Catalioto RM; Catalani C; Giuliani S; Quartara L; Giolitti A; Faiella A; Rotondaro L; Candenas ML; Pinto FM; Maggi CA
Eur J Pharmacol; 2004 Sep; 499(3):229-38. PubMed ID: 15381044
[TBL] [Abstract][Full Text] [Related]
59. Multiple tachykinin binding sites in hamster, rat and guinea-pig urinary bladder.
Burcher E; Buck SH
Eur J Pharmacol; 1986 Sep; 128(3):165-77. PubMed ID: 3024992
[TBL] [Abstract][Full Text] [Related]
60. Tachykinins and other biologically active peptides from the skin of the Costa Rican phyllomedusid frog Agalychnis callidryas.
Mignogna G; Severini C; Erspamer GF; Siciliano R; Kreil G; Barra D
Peptides; 1997; 18(3):367-72. PubMed ID: 9145422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
